Morinda Officinalis Oligosaccharides Alleviate Post‐Stroke Depression‐Like Behaviors Alongside Increased Gut Microbial Diversity and Butyrate Levels and Reduced Hippocampal Pla2g4a Expression
Morinda-Officinalis-Oligosaccharide lindern poststroke-ähnliches depressives Verhalten zusammen mit erhöhter Darmmikrobiom-Diversität und Butyratspiegeln sowie reduzierter Pla2g4a-Expression im Hippocampus
CNS Neuroscience & Therapeutics · 2026-11 · 32 (11)
DOI: 10.1002/cns.71238 ↗Auf einen Blick
In einem Mausmodell für poststroke-depressive Symptome war Morinda-Officinalis-Oligosaccharid mit weniger depressionsähnlichem Verhalten verbunden. Begleitend veränderten sich Darmmikrobiom, Butyrat und Pla2g4a im Hippocampus.
Fragestellung
Welche Wirkungen haben Morinda-Officinalis-Oligosaccharide in einem Mausmodell für poststroke-depressionsähnliches Verhalten?
Methode
Männliche C57BL/6J-Mäuse mit transientem MCAO und 21 Tagen CRS; MOO oral an Tag 7 bis 27. Untersucht wurden Verhalten, 16S-rRNA-Mikrobiomanalyse, SCFA, Barriereintegrität, Proteomik, FMT, Natriumbutyrat und Pla2g4a-Überexpression.
Ergebnisse
MOO veränderte die Darmmikrobiota, erhöhte nützliche Bakterien und senkte schädliche Bakterien sowie den fäkalen Butyratspiegel. Mit MOO und Natriumbutyrat verbesserten sich Marker der intestinalen und Blut-Hirn-Schranken-Integrität; Pla2g4a sank im Hippocampus.
Einschränkungen
FMT ergab nur vorläufige Evidenz; der Zusammenhang zwischen Pla2g4a und Butyrat wurde experimentell nur im Mausmodell geprüft.
Schlussfolgerung der Autor:innen
MOO war bei PSD-Mäusen mit verbesserten depressionsähnlichen Verhaltensweisen assoziiert, begleitet von Darmmikrobiom-Veränderungen, mehr fäkalem Butyrat, besserer Barriereintegrität und weniger hippocampaler Pla2g4a-Expression.
Kernaussagen
- MOO war mit weniger depressionsähnlichem Verhalten im PSD-Mausmodell verbunden.
- Fäkales Butyrat stieg an; die Darmmikrobiota veränderte sich.
- Pla2g4a im Hippocampus nahm ab; FMT lieferte nur vorläufige Evidenz.
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 30.10.2026. Verfasst von Hui Ma und 11 weiteren Autor:innen. Beteiligte Einrichtung: Academy of Military Medical Sciences, Academy of Military Sciences, Beijing, China. Hauptthemen laut MEDLINE: Hippocampus, Depression, Gastrointestinal Microbiome, Oligosaccharides. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Municipal Natural Science Foundation, Natural Science Foundation of Beijing Municipality.
Themen: Depression, Schlaganfall
Abstract (Originalsprache)
Background and Purpose Post‐stroke depression (PSD) represents a common and debilitating complication after cerebral ischemia, yet mechanism‐based therapies remain an urgent unmet need. The microbiota‐gut‐brain axis has been implicated in PSD pathophysiology, but the precise molecular pathways are largely elusive. Morinda officinalis oligosaccharides (MOO), a clinically approved antidepressant in China, exhibit poor oral absorption, raising the possibility of a gut‐dependent mechanism. Experimental Approach Male C57BL/6J mice were subjected to transient middle cerebral artery occlusion (MCAO) followed by 21 days of chronic restraint stress (CRS) to establish a PSD model. MOO (50 mg/kg/day) was administered via gavage from Day 7 to 27. Depression‐like behaviors, 16S rRNA‐based gut microbiota profiling, short‐chain fatty acid (SCFA) quantification, intestinal and blood–brain barrier integrity assessments, and hippocampal proteomics were performed. The transferability of MOO‐associated fecal effects was assessed using a donor‐controlled fecal microbiota transplantation (FMT) design. The butyrate‐Pla2g4a relationship was further examined by sodium butyrate supplementation and AAV‐mediated hippocampal Pla2g4a overexpression. Key Results MOO administration altered gut microbial composition, increased the abundance of probiotics and decreased the abundance of harmful bacteria, and was accompanied by increased fecal butyrate levels. The donor‐controlled FMT experiment provided preliminary evidence that fecally transferable factors from MOO‐treated PSD donors may contribute to behavioral improvements in PSD recipients. MOO and sodium butyrate treatment were associated with improved indices of intestinal and blood–brain barrier integrity. Hippocampal proteomics identified Pla2g4a, a phospholipase linked to neuroinflammation, as a candidate molecule related to the observed effects. Both MOO and sodium butyrate treatment were associated with reduced hippocampal Pla2g4a expression, and Pla2g4a expression was inversely correlated with butyrate levels. Hippocampal Pla2g4a overexpression attenuated the behavioral improvements associated with sodium butyrate treatment, supporting the functional involvement of Pla2g4a in the response to sodium butyrate. Conclusions and Implications MOO treatment was associated with improved depression‐like behaviors in PSD mice, accompanied by gut microbial alterations, increased fecal butyrate, improved barrier integrity, and reduced hippocampal Pla2g4a expression. FMT findings provided preliminary evidence that fecally transferable factors from MOO‐treated donors may contribute to behavioral improvements, while Pla2g4a overexpression attenuated the behavioral effects of sodium butyrate. These findings highlight a potential association among MOO, gut‐derived butyrate, barrier integrity, and hippocampal Pla2g4a in PSD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Academy of Military Medical Sciences, Academy of Military Sciences, Beijing, China.
- Graduate Collaborative Training Base of Academy of Military Medical Sciences, Hengyang Medical School, University of South China, Hengyang, China.
- Chinese PLA Medical School, Beijing, China.
- Anhui Medical University, Hefei, China.
Förderung
- National Natural Science Foundation of China
- Beijing Municipal Natural Science Foundation
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Ma, H., Chen, Y., Deng, X., Fang, X., Xiao, W., Long, Q., Du, L., Du, F., Chen, H., Wang, Y., Gao, B., & Qiao, X. (2026). Morinda Officinalis Oligosaccharides Alleviate Post‐Stroke Depression‐Like Behaviors Alongside Increased Gut Microbial Diversity and Butyrate Levels and Reduced Hippocampal Pla2g4a Expression. CNS Neuroscience & Therapeutics, 32(11). https://doi.org/10.1002/cns.71238
Vancouver
Ma H, Chen Y, Deng X, Fang X, Xiao W, Long Q, et al. Morinda Officinalis Oligosaccharides Alleviate Post‐Stroke Depression‐Like Behaviors Alongside Increased Gut Microbial Diversity and Butyrate Levels and Reduced Hippocampal Pla2g4a Expression. CNS Neuroscience & Therapeutics. 2026;32(11). doi:10.1002/cns.71238
BibTeX
@article{Ma2026,
author = {Ma, Hui and Chen, Yue and Deng, Xinzhou and Fang, Xuan and Xiao, Wenhui and Long, Qian and Du, Lu and Du, Fuze and Chen, Haonan and Wang, Yan and Gao, Bo and Qiao, Xin},
title = {Morinda Officinalis Oligosaccharides Alleviate Post‐Stroke Depression‐Like Behaviors Alongside Increased Gut Microbial Diversity and Butyrate Levels and Reduced Hippocampal Pla2g4a Expression},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
volume = {32},
number = {11},
doi = {10.1002/cns.71238}
}
EUVIMED